# A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

> **NCT03650933** · PHASE3 · UNKNOWN · sponsor: **Nanjing Yoko Biomedical Co., Ltd.** · enrollment: 360 (estimated)

## Conditions studied

- Diffuse Large B-Cell Lymphoma, Unspecified Site

## Interventions

- **BIOLOGICAL:** G-CHOP
- **BIOLOGICAL:** R-CHOP

## Key facts

- **NCT ID:** NCT03650933
- **Lead sponsor:** Nanjing Yoko Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-28
- **Primary completion:** 2022-08-17
- **Final completion:** 2025-12-31
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03650933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03650933, "A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03650933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*